Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.

MLA

Asim, Mohammad, et al. “Synthetic Lethality between Androgen Receptor Signalling and the PARP Pathway in Prostate Cancer.” Nature Communications, vol. 8, no. 1, Aug. 2017, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41467-017-00393-y.

APA

Asim, M., Tarish, F., Zecchini, H. I., Sanjiv, K., Gelali, E., Massie, C. E., Baridi, A., Warren, A. Y., Wanfeng Zhao, Ogris, C., McDuffus, L.-A., Mascalchi, P., Shaw, G., Dev, H., Wadhwa, K., Wijnhoven, P., Forment, J. V., Lyons, S. R., Lynch, A. G., & O, N. C. (2017). Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. Nature Communications, 8(1), 1–10. https://doi.org/10.1038/s41467-017-00393-y

Chicago

Asim, Mohammad, Firas Tarish, Heather I. Zecchini, Kumar Sanjiv, Eleni Gelali, Charles E. Massie, Ajoeb Baridi, et al. 2017. “Synthetic Lethality between Androgen Receptor Signalling and the PARP Pathway in Prostate Cancer.” Nature Communications 8 (1): 1–10. doi:10.1038/s41467-017-00393-y.